What's new in DyslipidemiaLast update of the site: Tuesday December 03, 2024
Kestecher Brachyahu M. et al. | Cardiovascular Diabetology 2024; 23(1):...
All mouse experiments followed procedures outlined by the Council Directive of the European Union (86/609/EEC),...
von Känel-Cordoba Isabel et al. | Journal of Health, Population and Nutrition...
Chronic diseases represent a significant global health challenge. Approximately one-third of adults worldwide...
Zhao Mengjie et al. | Lipids in Health and Disease 2024; 23(1):...
Diabetes mellitus (DM), a global health challenge, is characterized by high prevalence, low treatment...
Yu Bian
et al. | British Journal of Pharmacology 2024;...
Existing medications for hyperlipidaemia are limited by the adverse effect of liver damage.
Return...
Jiang Li et al. | Cardiovascular Diabetology 2024; 23(1):...
Diabetes mellitus, particularly type 2 diabetes mellitus (T2DM), is a growing global health concern and...
Koutaro
Yokote
MD et al. | Journal of the American Heart Association...
Evolocumab was safe and effective in Japanese patients with homozygous/heterozygous familial hypercholesterolemia...
Lyu Xuan et al. | BMC Cardiovascular Disorders 2024; 24(1):...
Familial hypercholesterolemia (FH) is a classic autosomal dominant hereditary disease, primarily caused...
Song Kaimin et al. | BMC Infectious Diseases 2024; 24(1):...
Despite the availability of safe and effective hepatitis B vaccine, hepatitis B virus (HBV) infection...
Canbay Erhan et al. | Lipids in Health and Disease 2024; 23(1):...
Oxysterols are oxidized derivatives of cholesterol that play significant roles in various biological...
Bibliographical searchFocus and target to your research of scientific data
Research by journal
1097 articles currently available
Search By Subject
Top articlesThe 5 most read articles
von Känel-Cordoba Isabel et al. | Journal of Health, Population and Nutrition...
Chronic diseases represent a significant global health challenge. Approximately one-third of adults worldwide are affected by multiple chronic conditions, including cardiovascular diseases, diabetes, depression,...
Kestecher Brachyahu M. et al. | Cardiovascular Diabetology 2024; 23(1):...
All mouse experiments followed procedures outlined by the Council Directive of the European Union (86/609/EEC), and prior to experimental work, approval was granted by Semmelweis University’s Institutional...
Zhao Mengjie et al. | Lipids in Health and Disease 2024; 23(1):...
Diabetes mellitus (DM), a global health challenge, is characterized by high prevalence, low treatment rates, and high mortality, exerting a heavy burden on individual health and the global health system....
Yu Bian
et al. | British Journal of Pharmacology 2024;...
Existing medications for hyperlipidaemia are limited by the adverse effect of liver damage.
Return to the table of contents...
Koutaro
Yokote
MD et al. | Journal of the American Heart Association...
Evolocumab was safe and effective in Japanese patients with homozygous/heterozygous familial hypercholesterolemia and hypercholesteremia with high risk in real‐world practice.
Low incidence rates...